BACE1 and Alzheimer disease: The drugs currently used for the AD treatment mainly act by inhibiting the enzyme acetylcholinesterase, so the discovery of the inhibition of the BACE-1 enzyme by phlorotannin may improve the drugs and treatment for patients affected by AD.